Injected drug reduces risk of fracture among women with osteoporosis

Posted by on August 16, 2016 4:06 pm
Categories: health

Among postmenopausal women with osteoporosis at risk of fracture, daily injection of the drug abaloparatide for 18 months significantly reduced the risk of new vertebral and nonvertebral fractures compared with placebo, according to a study.

Leave a Reply

Your email address will not be published. Required fields are marked *